Inhibition of lecithin: cholesterol acyltransferase following intravenous administration of heparin in man.
D000217:Acyltransferases / Q000037:antagonists & inhibitors* / Q000097:blood; D001665:Binding Sites; D002784:Cholesterol / Q000097:blood; D002855:Chromatography, Thin Layer; D004952:Esters; D005215:Fasting; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007275:Injections, Intravenous; D007700:Kinetics; D008244:Lysophosphatidylcholines / Q000494:pharmacology; D008297:Male; D010169:Palmitic Acids / Q000494:pharmacology; D010713:Phosphatidylcholines; D011485:Protein Binding; D012709:Serum Albumin / Q000494:pharmacology; D013997:Time Factors; D014280:Triglycerides / Q000097:blood; D014316:Tritium
D004952:Esters; D005230:Fatty Acids, Nonesterified; D008244:Lysophosphatidylcholines; D010169:Palmitic Acids; D010713:Phosphatidylcholines; D012709:Serum Albumin; D014280:Triglycerides; D014316:Tritium; D006493:Heparin; D002784:Cholesterol; D000217:Acyltransferases